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3'HVR DNA probe in PKD (abst) 1160
ACE inhibition
lisinopril 272
renal action of ANP (abst) 309
ANCAIACPA test to diagnose vasculitides (abst) 310
Abscess, renal and perirenal (abst) 1184
Acid
G-I absorption of alkali 915
Acid-base
balance, metabolic coma 1142
electrogenic Na/HCO3 cotransporter 392
Acidemia
bicarbonate distribution space 747
Acidosis
hypoxia in TAL 823
optimal correction 1112
Acromegalic, renal reserve capacity (abst) 507
Acromegaly, growth hormone, IGF-I S-20
Activity index, pathology in lupus nephritis 891
Acute pyelonephritis
parenchymal involvement (abst) 1178
Acute renal failure
after Neomycin/Bacitracin (abst) 317
aluminum hydroxide absorption (abst) 147
amino acid removal in CAVHD (abst) S-308
amyloidosis (abst) 145
bone marrow transplant (abst) 145
databolic effect of HD (abst) S-307
diltiazem and allopurinol (abst) 309
hypoxic, cation gradients (abst) 1172
ingestion of raw fish gall bladder (abst) 1183
mRNA and EGF excretion 810
nitrogen requirements (abst) S-308
PAF-acether (abst) 159
pentoxifylline 466
prepro-epidermal growth factor 810
PTH, elastase and PMNL 883
single nephron obstruction 1050
vasoconstriction (abst) 1184
Yersinia pseudotuberculosis infection (abst) 1183
Acyltransferase, lipids, nephrotic syndrome 240
Adenosine
fibroblast site of production of (abst) 319
receptors, contraction of mesangial cells (abst) 159
Adenylate cyclase
dopamine receptor subtypes 183
PTH response during compensatory renal growth 802
Adhesion molecules in human kidney 1078
Adriamycin
induced nephrosis, TIN (abst) 144
nephrosis, ANP 57
nephropathy, converting enzyme inhibition 816
Albumin
high protein diets, mRNA transcription S-168
platelet aggregability in NS 1119
Albuminuria
adriamycin-induced nephropathy 816
murine graft vs. host nephritis (abst) 512




aldehyde reductase localization 843
Aldosterone
citrate synthase in CCD (abst) 309
ratio in pregnancy with ANP 908
Aldosteronism
captopril test (abst) 1191
Alkali
method for estimating G-I absorption of 915
Alkaline phosphatase, localization in kidney 617
Alkalosis
bicarbonate distribution space 747
Allograft
ANP, 24-hour cold preservation 562
gamma-interferon (abst) 1169
survival rate (abst) 1190
Alloisoleucine
clearance in ketoacid-supplemented (abst) S-306
method and clearance S-177
Alpha-ANP in man 645
Alport's syndrome
bull terrier nephropathy (abst) 1170
identification of phenotypes 669
Aluminum
absorption is energy dependent (abst) 1173
anemia of terminal renal failure (abst) 158
changes after PTx 120
citrate, toxicity 949
deferoxamine in iron overload in HD 1125
gastrointestinal absorption by citrate 978
hydroxide absorption (abst) 147
induced anemia 852
inhibitory effect on parathyroid function (abst) 147
intoxication in uremia (abst) 146
needless risk for dialysis patients (abst) 1177
protein kinase C activation (abst) 1174
PTH blood levels in intoxication (abst) 148
Amiloid arthropathy in HD (abst) 148
Amiloride
cell volume regulation in IMCD 831
rubidium induced kaliuresis 175
Amino acid
alterations in, CRF (abst) S-30l
blood profiles abnormal post-meal S-212
branched chain, diet and hemodynamics (abst) S-301
CAPD fluid effect on protein losses (abst) S-302
correction of metabolism by rHuEPO S-2l6
diet and renal function S-68
formulation in hemodialysis S-278
hypertonic solutions (abst) S-303
induced natriuresis (abst) 510
ketoanalog mixture, CRF (abst) S-300
long term CAPD (abst) S-303
metabolism in uremia S-205
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plasma alloisoleucine s-I 77
sodium coupled, transport 351
Aminoguanidine in GBM (abst) 1166
Aminonucleosis nephrosis (abst) 308
Ammonia
complement, progressive renal injury S-52
Ammoniagenesis, metabolic acidosis (abst) 155
Ammonium
measurement by auto-analyzer method 291
Amyloid arthropathy
dialyzed patients (abst) 149




dialysis related (abst) 1166
Spanish Cooperative study of dialysis-related (abst) .. . 142
Anaphylaxis
PAF in CAPD 1029
Anemia
aluminum induced 852
erythroid progenitor cells 712
polyamines in ESRD 171
r-huEPO (abst) 325
sideroblastic, vitamin B6 deficiency (abst) 1179
vascular changes with r-HuEPO in HD 878
Angiography
to study AV fistula (abst) 159
nephrotoxicity of contrast media 730
Angiotensin
reduced receptor, pressor response in HD,
hypertension 696
Angiotensin II
mechanism of action in glomeruli 985
receptor density in anti-GBM disease (abst) 1163
Angiotensin converting enzyme inhibition
beneficial effects in models of disease (abst) 1179
felodipine (abst) 511
Heymann nephritis and dietary protein intake S-l54
hypertension and atrophy (abst) 1168
protein metabolism in nephrotic syndrome S-l63





a- and f3-adrenergic, renal Na/H exchanger (abst)... 312
Antibiotic
bonding, peritoneal catheters (abst) 154
diuretics 78
lactam, PT transport (abst) 311
prophylaxis during catheter placement (abst) 163
Antibodies
anti-basement membrane binding polyclonal
localized (abst) 1173
anti-neutrophil cytoplasm (abst) 1176
anticardiolipin, lesions, dimentia (abst) 510
detect CsA kinetics (abst) 324
identification of Alport phenotypes 669
initiated glomerulonephritis 537
lectin induces experimental GN 1011
leukotriene synthesis in Heymann nephritis 1006
neurological complications, OKT3 therapy (abst) 1179
neutrophil cytoplamic tests (abst) 1178
Antigen
abnormal expression in GN (abst) 308
distribution of Goodpasture (abst) 306
membranous nephropathy, hepatitis B 1103
parenchymal cell types of kidney and heart 228
reflect cell adaptation in RF S-38
schistosomal specific nephropathy 904
Antihypertensive therapy 526
Antineutrophil cytoplasm antibody, vasculitis (abst).... 1171
Antiport
Na-H activity in BBM 576
Anuric patient, lead (abst) 1171
Arginine vasopressin
increases ANF (abst) 157
Arterio-venous fistula
digital subtraction angiography (abst) 159
Doppler-duplex ultrasound (abst) 158




Arthropathies, HD related (abst) 5-305
Artificial kidney
bidirectional pump (abst) 1159
Ascites treatment with hemodialysis (abst) 1159
Atherosclerosis, hyperlipoproteinemia 266
Atrial natriuretic factor
liver cirrhosis with acites (abst) 323
Atrial natriuretic peptide
24-hour cold preservation 562
ACE inhibition (abst) 309
blunted excretory response to 57
physiological increments in man 645
RAAS in normotensives (abst) 158
ratio in pregnancy with aldosterone 908
volume expansion in diabetics (abst) 150
Atriopeptin II, RBF 13
Auto-analyzer method measures ammonium 291
Autoregulãtion
influence of sympathetic nerves (abst) 311
Autotransplantation, parathyroidectomy (abst) 1169
Azotemia
phosphate excess and progressive renal failure 918
Baboons
eight vs. 25% protein diet (abst) S-299
study of diet and renal function S-86
Barnett, Henry, John P. Peters award 127
Basolateral membranes
dopamine receptor subtypes 183




essential hypertension (abst) 156
Beta2-microglobulin
acute-phase reactant in dialysis (abst) 154
amyloid deposits, hemodialysis 675
CAPD (abst) 154
hemodialysis with cellulosic membrane (abst) 313
Bicarbonate
distribution space 747
protein kinase C 216
resorption in CCD (abst) 310
transport systems 392
xipamide (abst) 161
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Bioimpedance in CAPD (abst) S-306
Biopsy
fine-needle aspiration, transplantation 130
graft, CsA, transplantation (abst) 325
hematuria, hypercalciuria, hyperuircosuria 96
IL-2 receptors in allografts (abst) 152
percutaneous renal, day patient (abst) 1178
ultrastructural changes, glomerular bleeding 992
value of post-transplantation (abst) 162
Blood
bidirectional pump, artificial kidney (abst) 1159
dysmorphic erythrocytes 72
dysmorphism of urinary red cells 1045
flow, single nephron obstruction 1050
hemochromatosis, plasma filtration (abst) 1180
PAN and PS membranes (abst) S-308
platelet aggregability in NS 1119
renal flow, atriopeptin II 13
rheology, GN (abst) 1171
volume changes, short dialysis (abst) 322
Blood pressure
aortic-ligature and DOCA-salt hypertension (abst).... 1177
calcium antagonists therapy 295
factors for progressive renal disease S-106
metabolic coma 1142
post-transplant hypertension, Captopril 35
verapamil and exercise (abst) 158
Bone
calcitriol as early therapy of disease S-l40
correction of acidosis affects osteodystrophy rate . . . . 1112
disease strategy (abst) 1177
formation rate in dialysis patients (abst) 1174
formation, insulin-like growth factors 471
marrow, polyamines in anemia of ESRD 171
marrow transplantation, ARF (abst) 145
static histomorphometry (abst) 163
Bradykinin
effect of isolated perfused kidney (abst) 1183
Brain
abnormal norepinephrine uptake in CRF 458
Brush border membrane
alkaline phosphatase 617
dopamine receptor subtypes 183
indirect coupling between Na and urate transport 378
Na-H antiport activity 576
Na/H exchanger (abst) 312
PT inorganic phosphate reabsorption 360
regulation of Na-H exchanger 519
signal transduction (abst) 320
Bumetanide in hypertension 719
C3
decay accelerating factor localized 100
C3b receptors
various renal diseases (abst) 1181
C4 gene products in lupus nephritis (abst) 1169
C5b-9
excretion, Heymann nephritis 65
cAMP
caltitonin gene-related peptide 222
glucagon stimulates Cl transport in TAL 760
urokinase synthesis and binding, epithelial cells 593
CAPD
activation of immunocompetent cells 661
as treatment of heart failure (abst) 162
beta-2 microglobulin (abst) 154
body composition analysis (abst) S-306
calculating mass transfer coefficient (abst) 155
changing to hemodialysis (abst) 142
circadian rhythm (abst) 1167
congestive heart failure (abst) 1189
EDLS and hypertension (abst) 314
energy stores in muscle (abst) S-305
evolution in Catalonia (abst) 151
fish oil, hypertriglyceridemia (abst) S-304
hospital requirements in stable program (abst) 163
infectious peritonitis, PAF 1029
long term with amino acids (abst) S-303
metabolic and feeding conditions, 13 patients (abst). . S-303
mononuclear phagocyte proportions 20
muscle protein deficiency (abst) S-302
parathyroid lesions (abst) 154
peritonitis prevention (abst) 149
prevention of staphylococcal peritonitis (abst) 1189
prophylaxis of fungal peritonitis (abst) 326
protein malnutrition treatment (abst) S-303
r-HuEPO (abst) 508
serotonin and tryptophan (abst) S-302
Staphylococcus aureus nasal carriers (abst) 149
ticlopidine (abst) 163
tryptophan and muscle (abst) S-302
ultrafiltration, lymphatic absorption (abst) 322
urea nitrogen, protein, clearance (abst) S-303
CAT scan, gouty nephropathy (abst) 1178
CAVH
math model of solute transport (abst) 512
CAVHD, amino acid removal (abst) S-308
CD13 molecule (abst) 1165
cDNA probes in GBM (abst) 1160
CM V-infection of transplant patients (abst) 324
Cadmium
intoxication, glycosuria (abst) 1183
Calcitonin
gene-related peptide 222
ultraviolet irradiation, vitamin D S-143
Calcitriol
early therapy of bone disease S-140
inhibition, parathyroid function in dialysis 1093
metabolism, vitamin D in renal failure 234
Calcium
acetate as phosphorus binder 690
antagonist, nephrotoxicity in CsA (abst) 148
antagonist, nitrendipine 719
antagonists therapy for hypertension 295
BP and vitamin D (abst) 1162
carbonate, dialysate effect on mineral metabolism 897
mechanism of action of angiotensin II 985
metabolism, rhabdomiolysis (abst) 152
oral vs. Al(OH)3 as binders S-133
sensitive, phospholipid dependent protein kinase C.... 216
signal transduction 945
ultraviolet irradiation, vitamin D, calcitonin S-143
Calcium carbonate
hyperphosphatemia treatment in HD (abst) 326
phosphate binder, CRF (abst) 143
Calcium citrate
hemodialysis (abst) 315
Calcium oxalate nephrolithiasis, hypercalciuria 108
Cancer
dialysis after bilateral nephrectomy (abst) 315
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Capillary cross section, predictor of damage (abst) 152
Captopril
antihypertensive therapy 526
elderly, hypertension (abst) 143
long term in RF (abst) 1182
post-transplant hypertension 35
severe proteinuria in hypertensives (abst) 155
test in primary aldosteronism (abst) 1191
Cardiac
hypertrophy effect on survival in ESRD 286
Carpal tunnel syndrome
hemodialysis membrane (abst) 153
hemodialysis with AN 69 membrane (abst) 316
Catabolic patients need glutamine S-287
Catacholamine
level, HD, CRF (abst) 1188
dialysis membranes (abst) 315
Catheter
alternative pathway of complement 257
antibiotic bonding to (abst) 154
antibiotic prophylaxis (abst) 163
/32m levels, membrane kinetics (abst) 154
complications with permanent (abst) 155
fibrin sheet covering (abst) 1159
Cation
gradients in hypoxic ARF (abst) 1172
Cell
antigens reflect renal failure S-38
pathway of absorption of Alcit 978
protein catabolism S-Il
retinoic acid 954
PT phosphate reabsorption 360
signal transduction 945
to cell coupling (abst) 307
volume regulation in IMCD 831
Cellulosic hemodialysis membranes, complement 257
Center effect (abst) 142
Channel
water, cellular biology 497
Children
cationic protein in SRNS 867
congenital urinary tract anomalies (abst) 1184
cooperative study of MPGN (abst) 308
correct diagnosis of urinary tract infection (abst) 1185
ESRD(abst) 1161
idiopathic hypercalciuria (abst) 1182
low dose L-carnitine, lipid metabolism S-256
lupus nephritis (abst) 1185
membranous nephropathy, hepatitis B 1103
observation of SLE (abst) 1185
prognosis of GN (abst) 317
radiologic evaluation of urinary tract infection (abst).. 1185
sweet taste preference in uremic (abst) S-306
vesicoureteric reflux (abst) 318
Yersinia pseudotuberculosis infection, ARF (abst).... 1183
Chlorambucil, MGN (abst) 510
Chloride
mechanisms for apical Na-coupled transport 403
Na-K-Cl cotransporter in PCD 201
transport, glucagon vs. cAMP in TAL 760
Cholesterol
atheroembolic renal disease (abst) 315
dietary fish oil in SLE 653
emboli, renal failure (abst) 1169
Chronic pyelonephritis
scarring, E. coli 609
Chronic renal disease
dietary lipids and eicosanoids S-27
Chronic renal failure
5 years post-transplantation (abst) 156
abnormal norepinephrine uptake 458
alterations in plasma amino acids (abst) S-301
blood amino acid profile abnormal post-meal S-212
cystathionine (abst) S-30l
dietary compliance S-173
dipeptidyl aminopeitidase IV (abst) S-307
electromagnetic measurement (abst) 320
erythroid progenitor cells 712
fish oil, hyperlipidemia, hemodialysis S-239
glucose intolerance, verapamil 773
hypermetabolism (abst) 1161
hyperparathyroidism, vitamin D (abst) 1171
intradialytic parenteal nutrition (abst) S-303
ketoacids S-l22
lead intcxication (abst) 314
LEU7+ subpopulations (abst) 143
metabolic coma 1142
new ketoanalog and essential amino acid (abst) S-300
parathyroidectomy (abst) 1172
PTH, elastase and PMNL 883
progression factors S-106
progression, moderate diet restriction S-9l
protein restricted diet, 4 year follow-up S-96
reciprocal creatinine slopes S-8 1
reduced angiotensin receptors, pressor responses 696
Stockholm study S-l 10
Verona experience, diet S-l03
vitamin B6 requirements 702
Chronic renal insufficiency
different levels, nutritional status S-184
Chronicity index, pathology in lupus nephritis 891
Circadian rhythm in CAPD (abst) 1167
Cirrhosis
ANP, head-out water immersion (abst) 150
hypotension (abst) 323
Cisplatin
nephrotoxicity, sodium pump (abst) 1163
Citrate
gastrointestinal absorption of Al 978
oral Al compounds, toxicity 949
synthase, aldosterone in CCD (abst) 309
Class II antigen in parenchymal cells 228
Clearance
creatinine, urea, high flux hemodialysis (abst) 324
lithium, tubular Na handling 2
neutrophil-mediated post-ischemic tubular leakage .... 555
Clonidine
epinephrine effect of PTC (abst) 306
Cobra venom factor, lesions (abst) 307
Collecting duct
bicarbonate resorption (abst) 310
Coma, metabolic 1142
Compensatory renal growth
adenylate cyclase response from P1'H 802
Complement
activation in normal and diseased glomeruli 1069
activation, decay accelerating factor 100
alternative pathway, HD membranes 257
ammonia, renal injury S-52
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chemoattractant to anti-GBM GN (abst) 1175
expression of CR1 and CR3 in IgAN (abst) 1162
hypertensive glomerulopathy 582
oxydative metabolism in HD (abst) S-305
role of factor D (abst) 318
Computer in clinical service (abst) 1160
Congenital nephrogenic diabetes insipidus 859
Continuous flow apparatus, picomolar quantitation of
K 726
Contraluminal membrane
organic anion transport 370
Contrast media, RBF and atriopeptin II 13




cellular biology of water channel 497
Cortical collecting tubule
remnant kidney transport of Na 89
Corticosteroids, systemic vasculitis (abst) 145
Creatinine
chronic urea loading (abst) S-300
during progressive renal disease S-73
reciprocal slopes, CRF S-8 1
response to acute protein loading S-59
Crystal
glycosaminoglycans in stone formers 1022
Culture of rat kidney cells 228
Cuprophan
activated C3 binding sites 257
Cyclosporin A
adriamycin induced NS (abst) 313
Ca2 metabolism of neutrophils (abst) 308
calcium antagonist treatment (abst) 148
calcium antagonists, T cell (abst) 321
carbohydrate metabolism of liver cells S-236
causes of graft loss (abst) 1172
efficacy in triple-drug therapy (abst) 148
glucose intolerance, OGTT (abst) 1189
HLA typing (abst) 152
hyalinosis and sclerosis treatment (abst) 1162
living-related transplantation in Australia (abst) 1179
metabolism causes nephrotoxicity (abst) 1173
monotherapy post-transplantation (abst) 317
neurotransmitters in transplant patients (abst) 311
nifedipine, nephrotoxicity (abst) 151
von Willebrand factor (abst) 317
vs. azathioprine and prednisone (abst) 1174
Cyclosporine
acute dysfunction, dopamine infusion 1086
ang II, prostaglandin release (abst) 1167
conversion to conventional therapy (abst) 512
induced hypertension (abst) 1159
kinetics detected (abst) 324
not be given on per kg basis 321
or donor specific transfusions 485
psoriasis patients, fish oil (abst) 509
side effects—mode of action (abst) 310
study of Spanish Nephrology Society (abst) 142
tranfusion effect (abst) 153
two monoclonal assays (abst) 323
uninephrectomy and high protein feeding 194
Cyst
regression in PKD 960
Cystathionine in CRF (abst) S-301
Cytomegalovirus
disease prevention (abst) 512
infection, transplantation (abst) 163
dDAVP
epinephrine in diabetes 859





Al induced anemia in HD 852
iron-overloaded HD patients 1125
zygomycosis 1061
Dehydration, a-ANP in man 645
Deoxyspergualin, immunosuppressant (abst) 1170
Desferroxamine
anemia of terminal RF (abst) 158
Desoxycorticosterone, CS mice and injury 582
Diabetes
aldose and aldehyde reductase localization 843
effects of antihypertensive therapy 526
hyperglycemia, galactosemia 41
nephropathy, hypertension (abst) 1168
nitroprusside (abst) 1189
normoalbuminuric, dietary protein S-i 15
platelet factor 4 labeling (abst) 1162
proteinase activity S-55
Diabetes insipidus
epinephrine and dDAVP 859
three point linkage analysis (abst) 507
Diabetes mellitus
early changes in GFR (abst) 1163
metabolic coma 1142
post-transplantation (abst) 324
volume expansion, ANP (abst) 150
Diabetic nephropathy
correlations in 448 cases (abst) 309
Diagnosis
value of sonography (abst) 318
Dialysate
amino acid based, protein losses (abst) S-302
anti-viral factor 280
calcium carbonate, mineral metabolism 897
insulin (abst) 149
lipid response to L-carnitine S-259
low K to correct hyperkalemia (abst) 325
metabolic coma 1142
oral Ca vs. Al(OH)3 S-133
pulmonary damage in HD (abst) 144
supplementation with L-carnitine S-247
Dialysis
acute-phase reactants (abst) 154
Al induced anemia 852
amyloid arthropathy (abst) 149
amyloidosis (abst) 150
anti-viral factor in dialysate 280
/32m levels, kinetics of membranes (abst) 154
blood volume changes after short (abst) 322
bone formation rate (abst) 1174
calcitriol effect on parathyroid function 1093
complications with permanent catheters (abst) 155
correction of selenium S-274
early detection of venous stenoses 707
establishing criteria for adequate (abst) 161
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fluid, mononuclear phagocyte proportions . 20
hepatitis B vaccines (abst) 325
high-flux rapid (abst) 153
HIV evolution (abst) 156
long-term survival (abst) 147
membrane bioincompatability (abst) 145
metabolic coma 1142
modes compared (abst) 1189
needless risk with Al (abst) 1177
osteodystrophy, correction of acidosis 1112
prognosis post-bilateral nephrectomy (abst) 315
related amyloidosis (abst) 142, 1166
response of neutrophils to uremia S-293




severe dysfunction undectable 478
Diet
ACE inhibition by lisinopril 272
analysis of G-I absorption of alkali 915
and nephrotic syndrome S-152
baboon study of renal function S-86
branched chain amino acid diet (abst) S-301
compliance through computer-aided study (abst) .. .. S-306
creatinine during progressive renal disease S-73
CsA on carbohydrate metabolism S-236
determinants of progression of uremia (abst) 144
different protein loads in humans (abst) S-301
high protein, albumin mRNA S-168
hypertonic amino acid solutions (abst) S-303
kallikrein, dietary protein 998
metabolic and feeding in CAPD (abst) S-303
metabolism research at NIH (abst) S-300
normoalbuminuric diabetic patients S-l 15
nutritional status in different levels of CRF S-l84
obesity and high carbohydrate (abst) S-299
protein intake in humans S-64
protein restricted, limited indications S-96
reabsorption of inorganic phosphate 360
renal function S-68
Stockholm clinical study, CRF S-I 10
uninephrectomy and high protein feeding in CsA
nephropathy 194
Verona experience, renal failure S-103
Dilitiazem, allopurinol in ARF (abst) 308
Dipeptidyl aminopeptidase IV (abst) S-307
Dipyridamole
primitive GN (abst) 151
Distal tubule
electroneutral NaC1 transport 427
Diuretic
/3-lactam antibiotics 78
calcium antagonist therapy in hypertension 295
electroneutral NaCI transport 427
epinephrine and dDAVP, diabetes insipidus 859
furosemide 682
induced hyponatremia (abst) 1163
nitrendipine, bumetanide in hypertension 719
sodium-coupled ion cotransport and volume
regulation 434
Donor
transplantation with elderly (abst) 147
transplantation with infantile (abst) 148
Dopamine
receptor subtypes in BBM and BLM 183
reverses CsA induced dysfunction 1086
Doppler-duplex ultrasound (abst) 158
Dosage
CsA not be given on per kg basis (abst) 321
Drugs
antihypertensive, glomerular morphology 626
Dysmorphic erythrocytes 72
Dysmorphism of urinary red cells 1045
Ecto-5'-nucleotidase activity, mesangial cells 249
Edema
ANP in experimental nephrosis 57
renin-aldosterone axis in nephrotic (abst) S-307
Eicosanoid
dietary lipids, progression of renal disease S-27
leukotriene synthesis and Heymann nephritis 1006
Eicosapentenoic acid in SLE 653
Elastase
PTH and PMNL 883
Elderly
rural, hypertension (abst) 158
Electrolyte
balance, metabolic coma 1142
cellular biology of water channel 497
Electromagnetic measurement in CRF (abst) 320
Enalapril
adriamycin-induced nephropathy 816
reduced renal mass 969
resistant hypertension treatment (abst) 326
End-stage renal disease
anti-viral factor in dialysate 280
cyst regression in PKD 960
hypertrophy impact on survival 286
iron overload, deferoxamine, HD 1125
iron role in tubulointerstitial nephritis 753
lymphokine productivity (abst) 1182
peritoneal dialysis fluid, mononuclear phagocytes 20
polyamines and anemia 171
End-stage renal failure
Na, K ATPase inhibitor (abst) 1167
T cell preactivation in uremia 636
children, 16 years of experience (abst) 1161
infectious peritonitis, PAF, CAPD 1029
schistosomal specific nephropathy, therapy 904
vascular changes with r-HuEPO in HD 878
Endotoxin shock, ARF, hypoperfusion (abst) 509
Energy
Al absorption in duodenum (abst) 1173
muscle stores in CAPD (abst) S-305
Enzyme
antigen expression in parenchymal cell types 228
ketoacids, liver glutathione S-222
PTH, elastase, PMNL 883
Epidermal growth factor
polypeptide growth factors S-2
Epinephrine
clonidine, MDCK cells (abst) 306
dDAVP, diabetes insipidus 859
Epithelia I cells
retinoic acid, protein 954
urokinase synthesis and binding 593
Epitopes
anti-neutrophil cytoplasm antibodies (abst) 1176
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Erythrocyte
dysmorphic 72
Erythropoiesis, polyamines and anemia in ESRD 171
Erythropoietin
anemic patients on hemodialysis (abst) 325
CAPD (abst) 508
levels, transplantation (abst) 324
production related to PT (abst) 320
renin in polycythemic patients (abst) 321
vascular changes in HD 878
Escherichia coli
glomerular hemodynamics in endotoxemic rats 570
type 1 fimbriate strains 609
urinary tract infection (abst) 1184
Exchanger
electrogenic NaJHCO3 cotransporter 392
Excretion
G-I absorption of alkali 915
ammonium measurement by auto-analyzer 291
glycosaminoglycans, stone formers 1022
phosphate a progression indicator to CRF s-I 28
structural proteins in diabetes (abst) 307
superficial nephron segments cause sodium 601
Factor D, complement activation (abst) 318
Fatty acid
abnormalities in hemodialysis S-243
Felodipine, ACE inhibition (abst) 511




platelet aggregability in NS 1119
sheet covering dialysis catheters 1159




predicts outcome in vessel thrombi (abst) 1188
Fibroblast
site of production of interstitial adenosine (abst) 319
Fibronectin
collagen-binding complexes in IgAN (abst) 1170
Fine needle aspiration
biopsy 130
biopsy in rejection (abst) 146
monoclonal antibodies in biopsy, transplantation
(abst) 146
Fish oil
hyperlipidemia in HD (abst) S-304
hyperlipidemia of hemodialysis S-239
psoriasis, CsA treated (abst) 509
serum lipoproteins in HD (abst) 1164
supplements in SLE 653
Fistula
assessment monitor, stenosis (abst) 1167
early detection of venous stenoses 707
Fleroxacin metabolism in RF (abst) 318
Focal segmental glomerulonephritis
vasculitis and GN risk factors 1133
Food allergy and idiopathic nephrotic syndrome S-147
Furosemide
effect of Na intake (abst) 511
impaired natriuretic response 682
Galactosemia vs. diabetes 41
Gamma interferon
in allografts (abst) 1169
treatment, antigen expression 228
Gastro-intestinal absorption of alkali, estimates 915
Gemfibrozil, hyperlipoproteinemia 266
Genes
non-H-2, in immune complex nephritis 545
Glomerular basement membrane
aminoguanidine (abst) 1166
cDNA probes (abst) 1160
degrading neutral proteinase, mesangial cells 790
Glomerular extracellular matrix, proteinase 790
Glomerular filtration rate
calcitonin gene-related peptide 222
diabetes vs. galactosemia, hyperglycemia 41
dietary protein in humans S-64
different protein loads (abst) S-301
following diabetes mellitus (abst) 1163
high protein diet 441
kallikrein, protein 998
mechanism of action of angiotensin II 985
neutrophil-mediated post-ischemic tubular leakage .;.. 555
obstruction, leukocyte depletion 210
single nephron model of tubular injury 1037
Glomeruli
complement pathway 1069
mechanism of normal proteinuria (abst) 1179
permeability (abst) 1178
Glomerulonephritis
abnormal expression of antigens (abst) 308
anti-GBM, chemoattractant, complement (abst) 1175
antibody initiated 537
blood rheology (abst) 1171
complement activation in glomeruli 1069
cyclosporine, study in Spain (abst) 142
diffuse proliferative lupus 891
dysmorphism of urinary RBC 1045
experimental, lectin and antibodies 1011
genetic risk of hypertension (abst) 319
HTA prevalence (abst) 145
immunocytology of urine sediment (abst) 1160
LTB4 in nephrotoxic serum nephritis 46
macrophages, ecto-5 '-nucleotidase activity 249
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